New study aims to cut unnecessary prostate biopsies with smart monitoring

NCT ID NCT07180381

Recruiting now Diagnosis Sponsor: St. Antonius Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new strategy for diagnosing prostate cancer in men with moderate risk. Instead of immediately doing a biopsy, doctors will monitor them with regular PSA tests and MRI scans. The goal is to see if this approach can safely delay biopsies, avoid unnecessary procedures, and reduce overdiagnosis of slow-growing cancers that don't need treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Andros Clinics
RECRUITING

Arnhem, Gelderland, 6842 CV, Netherlands
Antoni van Leeuwenhoek Hospital
RECRUITING

Amsterdam, North Holland, Netherlands
Canisius Wilhelmina Hospital
RECRUITING

Nijmegen, Gelderland, Netherlands
Maasstad Hospital
NOT_YET_RECRUITING

Rotterdam, South Holland, Netherlands
Radboud University Medical Centre
RECRUITING

Nijmegen, Gelderland, 6525 GA, Netherlands
St Antonius Hospital
RECRUITING

Nieuwegein, Utrecht, 3435 CM, Netherlands
Treant
RECRUITING

Emmen, Drenthe, 7824AA, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.